Date: 23 March 2016
The RACGP supports the Pharmaceutical Benefits Advisory Committee (PBAC) proposed changes to the PBS listing of alprazolam.
The RACGP supports the proposed changes of:
- removing the 2mg strength of alprazolam from the PBS; and
- reducing the pack size from 50 tablets to 10 for the remaining strengths, will nil repeats.